Vaxxinity Alzheimer’s vaccine shows promise in clinical trials
New results from a phase 2A clinical trial show that the new Alzheimer’s disease vaccine from Vaxxinity has promising results.
Alzheimer’s disease vaccine candidates in 2023
This article discusses the list of vaccine candidates, along with clinical trials, for Alzheimer’s disease in 2023.
Alzheimer’s disease vaccine beginning clinical trials
The pharmaceutical company AC Immune SA has received FDA clearance to proceed with phase 1 and 2 clinical trials for its anti-amyloid beta vaccine for the treatment of Alzheimer’s disease. If the results of the clinical trial are positive, this… Read More »Alzheimer’s disease vaccine beginning clinical trials